Fresenius Medical Care (FME.DE) Stock Price

Fresenius Medical Care Price

🇩🇪XETRA·CLOSED
40.97EUR
Market closed
Today +/-
Today %

Fresenius Medical Care (FME.DE) Stock | ISIN DE0005785802 | WKN 578580. The current Fresenius Medical Care stock price is 40.97 EUR (2026). Revenue is 20.18 B EUR. Net income is 1.22 B EUR. The P/E ratio is 9.88. Market capitalization is 12.02 B EUR. Fresenius Medical Care operates in the Health sector.

Revenue has compounded at 6.9% per year over the past 19 years to 19.34 B EUR. Earnings per share have grown at 2.1% per year over the last 19 years. Fresenius Medical Care's net margin stands at 2.8%, down from 6.5% several years earlier. Fresenius Medical Care currently offers a dividend yield of about 2.9%. The payout ratio is around 66% of earnings. The dividend has grown at 0.3% per year over the past 19 years.

Fresenius Medical Care stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Fresenius Medical Care over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Fresenius Medical Care stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Fresenius Medical Care's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Fresenius Medical Care Stock Price History
DateFresenius Medical Care Price
Access this data via the Eulerpool API
Get Free API Key

Fresenius Medical Care Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
5.45 B EUR
756 M EUR
365 M EUR
Jan 1, 2006
6.77 B EUR
1.02 B EUR
427 M EUR
Jan 1, 2007
7.13 B EUR
1.17 B EUR
531 M EUR
Jan 1, 2008
7.23 B EUR
1.15 B EUR
557 M EUR
Jan 1, 2009
8.07 B EUR
1.26 B EUR
636 M EUR
Jan 1, 2010
9.09 B EUR
1.45 B EUR
742 M EUR
Jan 1, 2011
9.19 B EUR
1.48 B EUR
776 M EUR
Jan 1, 2012
10.96 B EUR
1.68 B EUR
920 M EUR
Jan 1, 2013
11.22 B EUR
1.66 B EUR
811 M EUR
Jan 1, 2014
12.14 B EUR
1.67 B EUR
781.34 M EUR
Jan 1, 2015
15.45 B EUR
2.1 B EUR
954.95 M EUR
Jan 1, 2016
16.57 B EUR
2.35 B EUR
1.14 B EUR
Jan 1, 2017
17.78 B EUR
2.54 B EUR
1.28 B EUR
Jan 1, 2018
16.55 B EUR
2.31 B EUR
1.98 B EUR
Jan 1, 2019
17.48 B EUR
2.29 B EUR
1.2 B EUR

Fresenius Medical Care Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 20, 2026, 9:02 AM
 
REVENUE (B EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B EUR)
NET INCOME (B EUR)
NET INCOME GROWTH (%)
DIV. (EUR)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
20242025e2026e2027e2028e2029e2030e2031e
19.3419.7520.1821.0122.6822.723.7924.26
-0.612.152.154.137.950.114.761.98
24.624.0823.5722.6420.9720.952019.61
4.764.764.764.764.764.764.764.76
0.541.161.221.381.641.71.871.95
7.83116.014.8313.5718.683.4210.324.12
1.191.442.532.94----
6.2521.0175.6916.21––––
293.41293.41293.41293.41293.41293.41293.41293.41
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Fresenius Medical Care generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Fresenius Medical Care retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Fresenius Medical Care's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Fresenius Medical Care has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Fresenius Medical Care's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Fresenius Medical Care stock margins

The Fresenius Medical Care margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fresenius Medical Care. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fresenius Medical Care.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
34.44 %
13.87 %
6.7 %
Jan 1, 2006
33.86 %
15.04 %
6.31 %
Jan 1, 2007
34.62 %
16.45 %
7.45 %
Jan 1, 2008
34.32 %
15.92 %
7.7 %
Jan 1, 2009
34.11 %
15.6 %
7.89 %
Jan 1, 2010
34.34 %
15.95 %
8.16 %
Jan 1, 2011
35.38 %
16.06 %
8.44 %
Jan 1, 2012
34.65 %
15.35 %
8.39 %
Jan 1, 2013
33.71 %
14.77 %
7.23 %
Jan 1, 2014
32.85 %
13.73 %
6.43 %
Jan 1, 2015
33.5 %
13.59 %
6.18 %
Jan 1, 2016
33.89 %
14.19 %
6.9 %
Jan 1, 2017
33.84 %
14.27 %
7.2 %
Jan 1, 2018
31.15 %
13.97 %
11.98 %
Jan 1, 2019
30.87 %
13.1 %
6.86 %

Fresenius Medical Care Stock Revenue, EBIT, Earnings per Share

The Fresenius Medical Care earnings per share therefore indicates how much revenue Fresenius Medical Care has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
18.6 EUR
2.58 EUR
1.25 EUR
Jan 1, 2006
22.87 EUR
3.44 EUR
1.44 EUR
Jan 1, 2007
23.99 EUR
3.95 EUR
1.79 EUR
Jan 1, 2008
24.26 EUR
3.86 EUR
1.87 EUR
Jan 1, 2009
27.06 EUR
4.22 EUR
2.13 EUR
Jan 1, 2010
30.1 EUR
4.8 EUR
2.46 EUR
Jan 1, 2011
30.14 EUR
4.84 EUR
2.54 EUR
Jan 1, 2012
35.7 EUR
5.48 EUR
3 EUR
Jan 1, 2013
36.77 EUR
5.43 EUR
2.66 EUR
Jan 1, 2014
40.1 EUR
5.51 EUR
2.58 EUR
Jan 1, 2015
50.63 EUR
6.88 EUR
3.13 EUR
Jan 1, 2016
54.03 EUR
7.66 EUR
3.73 EUR
Jan 1, 2017
57.81 EUR
8.25 EUR
4.16 EUR
Jan 1, 2018
53.85 EUR
7.52 EUR
6.45 EUR
Jan 1, 2019
57.74 EUR
7.56 EUR
3.96 EUR

Fresenius Medical Care business model & stock analysis

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease.

Fresenius Medical Care SWOT Analysis

Strengths

Fresenius Medical Care AG is a global leader in the field of dialysis and renal care, with a strong market presence in over 120 countries. The company benefits from its extensive network of clinics and partnerships, allowing it to provide comprehensive and high-quality services to patients worldwide.

The company's strong financial performance and profitability are key strengths, enabling it to invest in research and development, expand its operations, and attract top talent. Fresenius Medical Care AG's strong brand reputation and recognized expertise further contribute to its competitive advantage in the market.

Weaknesses

Despite its global presence, Fresenius Medical Care AG may face challenges in certain regions due to regulatory and reimbursement constraints. Adapting to diverse regulatory environments and addressing pricing pressures can potentially hinder the company's growth and profitability.

As a specialized healthcare provider, Fresenius Medical Care AG's success heavily relies on the availability of skilled healthcare professionals, efficient supply chain management, and technological advancements. Any weaknesses in these areas may impact the company's ability to deliver consistent and high-quality care to its patients.

Opportunities

The increasing incidence of chronic kidney diseases and the rising aging population present significant growth opportunities for Fresenius Medical Care AG. As the demand for renal care services continues to grow, the company can expand its market share by offering innovative treatment options and enhancing patient experience.

Strategic collaborations and partnerships with healthcare providers, research institutions, and technology companies can also open up new avenues for Fresenius Medical Care AG to develop and deliver advanced dialysis solutions. Additionally, entering emerging markets with underserved renal care needs can fuel the company's expansion and revenue growth.

Threats

Fresenius Medical Care AG operates in a highly competitive industry, facing competition from both established players and emerging entrants. Pricing pressures and the potential loss of key contracts can pose threats to the company's market position and profitability.

Rapid advancements in medical technology and the potential disruption caused by new treatment methods or alternative therapies also present threats to the traditional dialysis market, requiring Fresenius Medical Care AG to adapt and innovate to stay ahead.

Fresenius Medical Care Eulerpool Fair Value

Fresenius Medical Care historical P/E ratio, EBIT multiple, and P/S ratio

Fresenius Medical Care annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Fresenius Medical Care shares outstanding

The number of shares was Fresenius Medical Care in 2025 — This indicates how many shares 293.414 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
293 M base_Shares
Jan 1, 2006
296 M base_Shares
Jan 1, 2007
297 M base_Shares
Jan 1, 2008
298 M base_Shares
Jan 1, 2009
298 M base_Shares
Jan 1, 2010
302 M base_Shares
Jan 1, 2011
305 M base_Shares
Jan 1, 2012
307 M base_Shares
Jan 1, 2013
305 M base_Shares
Jan 1, 2014
302.87 M base_Shares
Jan 1, 2015
305.27 M base_Shares
Jan 1, 2016
306.7 M base_Shares
Jan 1, 2017
307.64 M base_Shares
Jan 1, 2018
307.28 M base_Shares
Jan 1, 2019
302.69 M base_Shares

Fresenius Medical Care Dividend History

28 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20251.44EUR↑ 21.0%1×
May 23, 20251.44EUR↑ 21.0%1/1
20241.19EUR↑ 6.2%1×
20231.12EUR↓ 17.0%1×
20221.35EUR↓ 49.8%1×
20212.69EUR↑ 124.2%2×
20201.2EUR↑ 2.6%1×
20191.17EUR↑ 10.4%1×
20181.06EUR↑ 10.4%1×
20170.96EUR↑ 20.0%1×
20160.8EUR↑ 2.6%1×

Fresenius Medical Care dividend history and estimates

In 2025, Fresenius Medical Care paid a dividend amounting to 1.44 EUR. Dividend means that Fresenius Medical Care distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2005
1.12 EUR
0 EUR
Jan 1, 2006
1.23 EUR
0 EUR
Jan 1, 2007
1.41 EUR
0 EUR
Jan 1, 2008
0.54 EUR
0 EUR
Jan 1, 2009
0.58 EUR
0 EUR
Jan 1, 2010
0.61 EUR
0 EUR
Jan 1, 2011
0.65 EUR
0 EUR
Jan 1, 2012
0.69 EUR
0 EUR
Jan 1, 2013
0.75 EUR
0 EUR
Jan 1, 2014
0.77 EUR
0 EUR
Jan 1, 2015
0.78 EUR
0 EUR
Jan 1, 2016
0.8 EUR
0 EUR
Jan 1, 2017
0.96 EUR
0 EUR
Jan 1, 2018
1.06 EUR
0 EUR
Jan 1, 2019
1.17 EUR
0 EUR

Fresenius Medical Care dividend payout ratio

In 2025, Fresenius Medical Care had a payout ratio of 60.4%. The payout ratio indicates the percentage of the company's profits that Fresenius Medical Care distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
29.86 %
Jan 1, 2006
28.47 %
Jan 1, 2007
26.26 %
Jan 1, 2008
28.88 %
Jan 1, 2009
27.23 %
Jan 1, 2010
24.9 %
Jan 1, 2011
25.59 %
Jan 1, 2012
23 %
Jan 1, 2013
28.2 %
Jan 1, 2014
29.85 %
Jan 1, 2015
24.92 %
Jan 1, 2016
21.45 %
Jan 1, 2017
23.08 %
Jan 1, 2018
16.43 %
Jan 1, 2019
29.52 %
Price targets and forecasts for Fresenius Medical Care are not yet available.

Fresenius Medical Care Earnings Estimates

Fresenius Medical Care Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
2/20/20230.69EUR5.28 BEUR2022 Q4
10/30/20220.68EUR5.12 BEUR2022 Q3
7/28/20220.83EUR4.84 BEUR2022 Q2
5/4/20220.7EUR4.54 BEUR2022 Q1
2/22/20220.88EUR4.68 BEUR2021 Q4
11/2/20210.92EUR4.54 BEUR2021 Q3
7/30/20210.76EUR4.38 BEUR2021 Q2
5/6/20210.8EUR4.29 BEUR2021 Q1
2/23/20211.21EUR4.52 BEUR2020 Q4
10/29/20201.16EUR4.46 BEUR2020 Q3
...

EESG©

Eulerpool ESG Scorecard© for the Fresenius Medical Care stock

81/100
70
Environment
86
Social
88
Governance
E

Environment

20
Scope 1 - Direct Emissions360,803
Scope 2 - Indirect emissions from purchased energy450,611
Scope 3 - Indirect emissions within the value chain2,993,388
Total CO₂ emissions811,414
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides—
Palm Oil
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees70
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Fresenius Medical Care shareholder structure

% Name
28.55369%
Fresenius SE & Co KGaA
Fresenius SE & Co KGaA
5.2%
Pzena Investment Management, LLC
Pzena Investment Management, LLC
5.01054%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
4.97569%
Dodge & Cox
Dodge & Cox
3.01452%
Artisan Partners Limited Partnership
Artisan Partners Limited Partnership
2.98139%
Harris Associates L.P.
Harris Associates L.P.
2.40875%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
2.22382%
DWS Investment GmbH
DWS Investment GmbH
0.81251%
Fiduciary Management, Inc.
Fiduciary Management, Inc.
0.78782%
BlackRock Advisors (UK) Limited
BlackRock Advisors (UK) Limited
...

Fresenius Medical Care Executives and Management Board

HG

Ms. Helen Giza

(57)

Chairman of the Management Board, Chief Executive Officer

Compensation4.44 M EUR
CC

Mr. Craig Cordola

(54)

Member of the Management Board, Chief Executive Officer - Care Delivery

Compensation3.72 M EUR
KM

Dr. Katarzyna Mazur-Hofsaess

(62)

Member of the Management Board, Chief Executive Officer - Care Enablement

Compensation3.28 M EUR
FM

Dr. Frank Maddux

(68)

Member of the Management Board, Global Chief Medical Officer

Compensation2.76 M EUR
MF

Mr. Martin Fischer

(49)

Chief Financial Officer, Member of the Management Board

Compensation2.52 M EUR

Frequently asked questions about Fresenius Medical Care

Fresenius Medical Care AG is a leading global provider of dialysis products, services, and solutions for patients with chronic kidney failure. The company's business model revolves around providing high-quality dialysis care to patients in over 120 countries. Fresenius Medical Care AG offers a comprehensive range of dialysis machines, dialyzers, and other related products to ensure efficient and effective treatment. Furthermore, the company operates a network of dialysis clinics, providing personalized care for patients worldwide. With a focus on innovation, research, and development, Fresenius Medical Care AG continuously strives to enhance patient outcomes and improve the overall quality of life for individuals with kidney disease.

All fundamentals and in-depth analysis of Fresenius Medical Care

Our stock analysis for Fresenius Medical Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius Medical Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Fresenius Medical Care Stock
Fresenius Medical Care Revenue→
Fresenius Medical Care Stock
Fresenius Medical Care Net Income→
Fresenius Medical Care Stock
Fresenius Medical Care P/E→
Fresenius Medical Care Stock
Fresenius Medical Care P/S→
Fresenius Medical Care Stock
Fresenius Medical Care EBIT→
Fresenius Medical Care Stock
Fresenius Medical Care Dividend→
Fresenius Medical Care Stock
Fresenius Medical Care Directors Dealings→
Fresenius Medical Care Stock
Fresenius Medical Care Stocks→
Fresenius Medical Care Stock
Fresenius Medical Care Market capitalization→
Fresenius Medical Care Stock
Fresenius Medical Care Debt→
Fresenius Medical Care Stock
Fresenius Medical Care Liabilities→
Fresenius Medical Care Stock
Fresenius Medical Care Equity→
Fresenius Medical Care Stock
Fresenius Medical Care AAQS→
Fresenius Medical Care Stock
Fresenius Medical Care Employees→
Fresenius Medical Care Stock
Fresenius Medical Care ROE→
Fresenius Medical Care Stock
Fresenius Medical Care ROA→
Fresenius Medical Care Stock
Fresenius Medical Care ROCE→